GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3266)

  • GC91820 structure
    GC91820PDIC-NS
    Purity: >95.00%

    PDIC-NS is an activator of stimulator of interferon genes (STING).

  • GC91967 structure
    GC91967LMTK3 Inhibitor C28
    CAS: 2764850-23-7
    Purity: >98.00%

    LMTK3 Inhibitor C28 ist ein Multikinasehemmer.

  • GC91977 structure
    GC91977TrkB Agonist Prodrug R13
    CAS: 1609067-49-3
    Purity: >95.00%

    TrkB Agonist Prodrug R13 (R13) ist eine Prodrugform des Tropomyosin-bezogenen Kinase B (TrkB)-Aktivators 7,8-Dihydroxyflavons.

  • GC92023 structure
    GC92023PTX80
    CAS: 2376297-69-5
    Purity: >95.00%

    PTX80 ist ein Antagonist von p62 (IC50 bis 31.18 nM für den menschlichen Rezeptor).

  • GC92037 structure
    GC92037JQKD82 (hydrochloride)
    CAS: 2863676-87-1
    Purity: >98.00%

    JQKD82 (hydrochloride) ist eine Prodrugform von KDM5-C49, einem Inhibitor der Jumonji AT-reichen interaktiven Domäne 1A (JARID1A), auch bekannt als Lysin-spezifische Demethylase 5A (KDM5A).

  • GC92066 structure
    GC92066RMC-6236
    CAS: 2765081-21-6
    Purity: >99.00%

    RMC-6236 ist ein nicht-kovalenter Inhibitor von GTP-gebundenem RAS.

  • GC92074 structure
    GC920741,2,3-Trioleoyl Glycerol-d5
    CAS: 60892-83-3
    Purity: >99.00%

    1,2,3-Trioleoyl Glycerol-d5 ist zur Verwendung als interner Standard für die Quantifizierung von 1,2,3-Trioleoylglycerin durch GC- oder LC-MS bestimmt.

  • GC92099 structure
    GC92099MSG606 (trifluoroacetate salt)
    Purity: >95.00%

    MSG606 (trifluoroacetate salt) ist ein Peptidantagonist des Melanocortinrezeptors 1 (MC1R; IC50,17 nM für den menschlichen Rezeptor) und ein Derivat des γ-Melanozyten-stimulierenden Hormons (γ-MSH).

  • GF04703 structure
    GF04703Phosphocreatine di-tris salt
    CAS: 108321-17-1
    Purity: >97.00%

    Phosphocreatine di-tris salt is a phosphorylated creatine molecule that serves as a high-energy phosphate reservoir in the muscles of vertebrates and some invertebrates, providing phosphate for the conversion of ADP to ATP.

  • GF11023 structure
    GF11023Hecubine
    CAS: 62874-52-6
    Purity: >98.00%

    Hecubine is a natural aspidosperma-type alkaloid found in E. officinalis , with anti-neuroinflammation properties.

  • GF15486 structure
    GF15486Cathepsin B from bovine spleen
    CAS: 9047-22-7

    Cathepsin B from bovine spleen(Cathepsin B) gehört zur Familie der Papain-ähnlichen Cysteinproteasen. Cathepsin B wird als Präproenzym synthetisiert, das aus 335 Aminosäuren besteht. Das berechnete Molekulargewicht beträgt circa 36.7 kDa. Cathepsin B ist im endosomalen/lysosomalen Kompartiment lokalisiert. Cathepsin B wirkt sowohl als Endopeptidase als auch als Exopeptidase. Cathepsin B beteiligt sich vor allem am regulären Umsatz intrazellulärer und extrazellulärer Proteine. Dadurch erhält es die homöostatische Stoffwechsel-Aktivität innerhalb der Zelle aufrecht.

  • GF17531 structure
    GF175318-Epixanthatin
    CAS: 30890-35-8
    Purity: >98.00%

    8-Epixanthatin is a light-induced growth inhibitor that regulates the phototropic curvature in sunflower hypocotyls.

  • GN10005 structure
    GN10005Schisandrin C
    CAS: 61301-33-5
    Purity: >99.50%
  • GN10017 structure
    GN10017Wogonin
    CAS: 632-85-9
    Purity: >98.00%

    Wogonin is a potent and competitive inhibitor of CYP1A2 with a K i value of 0.24μM.

  • GN10019 structure
    GN10019Ginsenoside Rg6
    CAS: 147419-93-0
    Purity: >99.50%
  • GN10030 structure
    GN10030Fisetin
    CAS: 528-48-3
    Purity: >98.00%

    Fisetin is a natural flavonol found in many fruits and vegetables with multiple biological activities.

  • GN10035 structure
    GN100359-Methoxycamptothecin
    CAS: 19685-10-0
    Purity: >99.00%
  • GN10037 structure
    GN10037Bisdemethoxycurcumin
    CAS: 33171-05-0
    Purity: >98.00%
  • GN10038 structure
    GN10038Ginsenoside Rh3
    CAS: 105558-26-7
    Purity: >99.50%
  • GN10040 structure
    GN10040Dehydrocorydaline
    CAS: 30045-16-0
    Purity: >98.00%

    Dehydrocorydaline is one of the quaternary ammonium alkaloids from Corydalis Rhizoma.

  • GN10045 structure
    GN10045Angelicin
    CAS: 523-50-2
    Purity: >99.50%
  • GN10055 structure
    GN10055Mulberroside A
    CAS: 102841-42-9
    Purity: >98.00%
  • GN10056 structure
    GN10056Dihydroartemisinin
    CAS: 71939-50-9
    Purity: >98.00%

    Dihydroartemisinin (DHA) is an active metabolite of artemisinin and its derivatives (ARTs) and is an effective drug widely used in the clinic to treat malaria.

  • GN10065 structure
    GN100652-Atractylenolide
    CAS: 73069-14-4
    Purity: >98.00%